Evidence for the use of PN in the PICU
99
5
19.
Vlasselaers D, Milants I, Desmet L, et al. Intensive insulin therapy for patients in paediatric intensive
care: a prospective, randomised controlled study. Lancet 2009;373:547-56.
20.
Macrae D, Grieve R, Allen E, et al. A randomized trial of hyperglycemic control in pediatric intensive
care. N Engl J Med 2014;370:107-18.
21.
Lacroix J, Hebert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive
care units. N Engl J Med 2007;356:1609-19.
22.
Ohye RG, Sleeper LA, Mahony L, et al. Comparison of shunt types in the Norwood procedure for
single-ventricle lesions. N Engl J Med 2010;362:1980-92.
23.
Agus MS, Steil GM, Wypij D, et al. Tight glycemic control versus standard care after pediatric cardiac
surgery. N Engl J Med 2012;367:1208-19.
24.
Hoffman TM, Wernovsky G, Atz AM, et al. Efficacy and safety of milrinone in preventing low cardiac
output syndrome in infants and children after corrective surgery for congenital heart disease.
Circulation 2003;107:996-1002.
25.
Hutchison JS, Ward RE, Lacroix J, et al. Hypothermia therapy after traumatic brain injury in children.
N Engl J Med 2008;358:2447-56.
26.
Takala J, Ruokonen E, Webster NR, et al. Increased mortality associated with growth hormone
treatment in critically ill adults. N Engl J Med 1999;341:785-92.
27.
Casaer MP, Mesotten D, Hermans G, et al. Early versus late parenteral nutrition in critically ill adults.
N Engl J Med 2011;365:506-17.
28.
Briassouli E, Briassoulis G. Glutamine randomized studies in early life: the unsolved riddle of
experimental and clinical studies. Clin Dev Immunol 2012;2012:749189.
29.
Heyland D, Muscedere J, Wischmeyer PE, et al. A randomized trial of glutamine and antioxidants in
critically ill patients. N Engl J Med 2013;368:1489-97.
30.
van Zanten AR, Hofman Z, Heyland DK. Consequences of the REDOXS and METAPLUS Trials: The End
of an Era of Glutamine and Antioxidant Supplementation for Critically Ill Patients? JPEN J Parenter
Enteral Nutr 2015;39:890-2.
31.
Tao KM, Li XQ, Yang LQ, et al. Glutamine supplementation for critically ill adults. Cochrane Database
Syst Rev 2014;9:CD010050.
32.
Trivedi A, Sinn JK. Early versus late administration of amino acids in preterm infants receiving
parenteral nutrition. Cochrane Database Syst Rev 2013;7:CD008771.
33.
Drenckpohl D, McConnell C, Gaffney S, Niehaus M, Macwan KS. Randomized trial of very low birth
weight infants receiving higher rates of infusion of intravenous fat emulsions during the first week
of life. Pediatrics 2008;122:743-51.
34.
Fischer CJ, Maucort-Boulch D, Essomo Megnier-Mbo CM, Remontet L, Claris O. Early parenteral
lipids and growth velocity in extremely-low-birth-weight infants. Clin Nutr 2014;33:502-8.
35.
Casaer MP, Van den Berghe G. Nutrition in the acute phase of critical illness. N Engl J Med
2014;370:1227-36.
36.
Doig GS, Simpson F, Early PNTIG. Early parenteral nutrition in critically ill patients with short-
term relative contraindications to early enteral nutrition: a full economic analysis of a multicenter
randomized controlled trial based on US costs. Clinicoecon Outcomes Res 2013;5:369-79.
37.
Heidegger CP, Berger MM, Graf S, et al. Optimisation of energy provision with supplemental
parenteral nutrition in critically ill patients: a randomised controlled clinical trial. Lancet
2013;381:385-93.
38.
Hermans G, Casaer MP, Clerckx B, et al. Effect of toleratingmacronutrient deficit on the development
of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. Lancet Respir Med
2013;1:621-9.
39.
Vanwijngaerden YM, Langouche L, Brunner R, et al. Withholding parenteral nutrition during
critical illness increases plasma bilirubin but lowers the incidence of biliary sludge. Hepatology
2014;60:202-10.




